The report summarizes the findings of an allocative and implementation efficiency analysis of Zimbabwe's HIV response across the care cascade, which was conducted using the Optima-HIV model. The analysis was conducted to support Zimbabwe in its decision-making on strategic HIV investments,...

This report summarizes the findings of an allocative efficiency study of Romania’s Tuberculosis (TB) response, which was conducted using the Optima-TB model. The analysis was conducted to support Romania in its decision-making on strategic TB investments during the current National Strategic...

This report summarizes findings of an HIV allocative efficiency study conducted in Kenya between 2018 and 2020. The study was commissioned to contribute to the evidence base for strategic planning processes at national and county level. This report documents the epidemiological impact of...

International investment in the response to HIV and AIDS has plateaued and its future level is uncertain. With many countries committed to ending the epidemic, it is essential to allocate available resources efficiently over different response periods to maximize impact. The objective of this...

This report summarizes the findings of an allocative efficiency analysis on Sudan s national HIV epidemic and response conducted in 2014. HIV allocative efficiency studies are generally trying to answer the question How can HIV funding be optimally allocated to the combination of HIV response...

Eswatini achieved a 44% decrease in new HIV infections from 2014 to 2019 through substantial scale-up of testing and treatment. However, it still has one of the highest rates of HIV incidence in the world, with 14 infections per 1,000 adults 15-49 years estimated for 2017. The Government of...

With limited funds available, meeting global health targets requires countries to both mobilize and prioritize their health spending. Within this context, countries have recognized the importance of allocating funds for HIV as efficiently as possible to maximize impact. Over the past six years,...

Indonesia is the third largest contributor to the global tuberculosis (TB) burden and among the top twenty countries in the world for TB-HIV (human immunodeficiency virus) coinfection, and multidrug-resistant TB (MDR-TB). In addition to the significant toll of TB to health and human capital, the...

Despite a non-decreasing HIV epidemic, international donors are soon expected to withdraw funding from Kazakhstan. Here we analyze how allocative, implementation, and technical efficiencies could strengthen the national HIV response under assumptions of future budget levels. We used the Optima...

The Eastern Europe and Central Asia region has the world’s fastest growing HIV epidemic. Although still concentrated, the epidemic has diversified, affecting several key populations in many countries. This change has increased the number of people in need, the ways the epidemic can spread, and...